CLINICAL_TRIALS
trial_result
· 2014-03-21
Clinical Trial Update: Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease [NA]
Summary
A completed clinical trial from the University of Kansas evaluated the role of extrarenal 1-alpha-hydroxylase in patients with end-stage renal disease, with res…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Kansas | Conditions: End-Stage Renal Disease | NA | Status: COMPLETED | Results posted: 2014-03-21